MarketCap
PMV Pharmaceuticals PMVP
$ 1.25
-2.34%
Facebook
X
Telegram
PMV Pharmaceuticals PEG Ratio | PMVP
Annual PEG Ratio PMV Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.306 | - | - | - | - | 0.0304 | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.306 | 0.0304 | 0.168 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Inozyme Pharma
INZY
|
-0.0361 | - | - | $ 207 M |  USA |
 |
Idera Pharmaceuticals
IDRA
|
-0.000442 | - | -23.04 % | $ 26.6 M | USA |
 |
NanoString Technologies
NSTG
|
-0.154 | - | -37.43 % | $ 5.1 M | USA |
 |
Humanigen
HGEN
|
-0.00141 | - | -81.12 % | $ 4.28 M | USA |
 |
Sorrento Therapeutics
SRNE
|
0.018 | - | -29.58 % | $ 126 M | USA |
 |
Surface Oncology
SURF
|
0.0307 | - | - | $ 59.7 M | USA |
 |
GlaxoSmithKline plc
GSK
|
4.02 | $ 50.28 | -0.27 % | $ 204 B |  Britain |
 |
Sierra Oncology
SRRA
|
-0.00778 | - | -0.05 % | $ 1.34 B |  Canada |
 |
Cocrystal Pharma
COCP
|
-0.00606 | $ 1.03 | 2.95 % | $ 11.6 M | USA |
 |
Atea Pharmaceuticals
AVIR
|
0.0231 | $ 4.27 | 1.18 % | $ 348 M | USA |
 |
Vaccinex
VCNX
|
-0.000064 | - | -61.37 % | $ 654 K | USA |
 |
ImmuCell Corporation
ICCC
|
0.153 | $ 9.9 | -0.5 % | $ 89.4 M | USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
0.229 | - | -19.68 % | $ 18.4 M | Canada |
 |
Akero Therapeutics
AKRO
|
-1.49 | - | - | $ 3.67 B | USA |
 |
Jounce Therapeutics
JNCE
|
0.0118 | - | - | $ 98.4 M | USA |
 |
Immutep Limited
IMMP
|
1.57 | $ 3.25 | 20.82 % | $ 4.73 B |  Australia |
 |
Verona Pharma plc
VRNA
|
0.194 | - | - | $ 69.7 B | Britain |
 |
Keros Therapeutics
KROS
|
-0.736 | $ 9.32 | -1.43 % | $ 347 M | USA |
 |
Kazia Therapeutics Limited
KZIA
|
5.03 | $ 7.19 | 2.71 % | $ 110 M | Australia |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
0.177 | $ 306.2 | 2.41 % | $ 5.92 B | USA |
 |
Acorda Therapeutics
ACOR
|
-0.000085 | - | -24.86 % | $ 820 K | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-0.000175 | - | -11.43 % | $ 502 K | USA |
 |
Akari Therapeutics, Plc
AKTX
|
13.5 | $ 7.95 | 2.57 % | $ 535 B | Britain |
 |
Mersana Therapeutics
MRSN
|
0.0284 | - | - | $ 3.56 B | USA |
 |
CymaBay Therapeutics
CBAY
|
-15.6 | - | - | $ 3.45 B | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
-0.0155 | - | - | $ 384 M | Britain |
 |
Genmab A/S
GMAB
|
0.277 | $ 53.62 | 1.67 % | $ 3.47 B |  Danmark |
 |
Allakos
ALLK
|
-0.0646 | - | - | $ 28.6 M | USA |
 |
Timber Pharmaceuticals
TMBR
|
-0.000998 | - | - | $ 717 K | USA |
 |
Ionis Pharmaceuticals
IONS
|
-0.0651 | $ 39.67 | 2.24 % | $ 6.35 B | USA |
 |
Iovance Biotherapeutics
IOVA
|
0.00041 | $ 8.1 | 4.59 % | $ 2.89 M | USA |
 |
Immuron Limited
IMRN
|
4.81 K | $ 0.82 | -3.68 % | $ 189 M | Australia |
 |
G1 Therapeutics
GTHX
|
0.377 | - | - | $ 370 M | USA |
 |
Amryt Pharma plc
AMYT
|
-0.174 | - | - | $ 621 M | Britain |
 |
MediWound Ltd.
MDWD
|
0.0499 | $ 14.18 | 6.38 % | $ 386 M |  Israel |
 |
Kinnate Biopharma
KNTE
|
-0.0131 | - | - | $ 123 M | USA |
 |
Nektar Therapeutics
NKTR
|
-0.081 | $ 37.25 | 3.04 % | $ 628 M | USA |
 |
Immunome
IMNM
|
-0.291 | $ 18.71 | 4.5 % | $ 1.63 B | USA |
 |
Kala Pharmaceuticals
KALA
|
-0.000055 | $ 0.16 | 2.1 % | $ 1.3 M | USA |
 |
Theravance Biopharma
TBPH
|
-0.0721 | $ 17.03 | 0.03 % | $ 857 M |  Cayman-islands |
 |
IMV
IMV
|
-0.283 | - | - | $ 13.1 M | Canada |
 |
Karuna Therapeutics
KRTX
|
-1.6 | - | - | $ 12.2 B | USA |
 |
Chimerix
CMRX
|
-0.042 | - | - | $ 756 M | USA |
 |
Atreca
BCEL
|
0.187 | - | -11.76 % | $ 5.79 M | USA |
 |
LogicBio Therapeutics
LOGC
|
-0.308 | - | - | $ 229 M | USA |
|
89bio
ETNB
|
-0.759 | - | - | $ 1.55 B | USA |
 |
Fusion Pharmaceuticals
FUSN
|
-0.0189 | - | - | $ 1.41 B | Canada |